Advertisement

Search Results for "oxford-vaccine-group"

Forbes List Logo
Doing the right thing?
A complex mix of culture, compensation, and relative moral standards makes it difficult for individuals in the financial sector to identify ethically right actions
ByOxford Said
Create a bigger pie
ByOxford Said
Marketing's post-digital age
ByOxford Said
Analysis: Reputational Risk in the Supply Chain
ByOxford Said
The Phoenix Economy
BySaid School Of Business
India approves Oxford-AstraZeneca COVID-19 vaccine and one other
Keep it Complex, Stupid
BySaid School Of Business
Europe, The Great Spectator
BySaid School Of Business
Don't stop thinking about tomorrow
BySaid School Of Business
"I have always been supportive of a more intensive and intrusive supervisory approach"
BySaid School Of Business
An Indian Rendezvous at Oxford
ByN.S. Ramnath
Network18 Organises India Day @Oxford
ByForbes India
Metaverse may become Oxford Word of the Year
ByShashank Bhardwaj
...

Latest News

How duopoly markets are quietly reshaping India’s economy
ByBharatiya Vidya Bhavan's SPJIMR
The more people wear Apple Watches, the better for us: Seiko Watch India COO
ByJasodhara Banerjee
Photo of the day: India Art Fair kicks off in Delhi
ByForbes India
RBI likely to hold interest rates in February 6 policy meet
BySalil Panchal
Economists flag upside to India growth after US tariff deal, but hold forecasts
BySamreen Wani
Why current tech stacks will fail DPDP (And what needs to change)
ByRoshmik Saha
Non-veg milk: The bone of contention in India-US trade deal
BySamidha Jain
Graphic of the day: Tariff relief cost: $2.5 trillion
BySamreen Wani
Why India’s IT giants are worried about Anthropic’s Claude Cowork
ByNaini Thaker
Advertisement
Advertisement

On Everyone’s Radar

Advertisement